- Home
- ZS vs BNTX Comparison
ZS vs BNTX Comparison
Compare ZS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZS | BNTX |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0B | 24.8B |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZS | BNTX |
|---|---|---|
| Price | $230.46 | $94.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 34 | 11 |
| Target Price | ★ $323.73 | $137.40 |
| AVG Volume (30 Days) | ★ 1.9M | 1.6M |
| Earning Date | 11-25-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,833,272,000.00 | ★ $3,698,814,972.00 |
| Revenue This Year | $27.01 | $2.03 |
| Revenue Next Year | $19.32 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23.24 | 3.70 |
| 52 Week Low | $164.78 | $81.20 |
| 52 Week High | $336.99 | $129.27 |
Technical Indicators
Market Signals| Indicator | ZS | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 30.81 | 44.49 |
| Support Level | $226.78 | $91.32 |
| Resistance Level | $234.93 | $96.19 |
| Average True Range (ATR) | 5.42 | 2.06 |
| MACD | 1.61 | 0.30 |
| Stochastic Oscillator | 16.75 | 41.78 |
Price Performance
Historical ComparisonAbout ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.